Temasek Holdings (Private) Ltd - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
Temasek Holdings (Private) Ltd ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2023$125,927,453
-6.9%
5,133,610
-11.7%
0.73%
-9.2%
Q1 2023$135,314,398
-6.4%
5,814,972
+1.8%
0.80%
-5.0%
Q4 2022$144,533,008
+24.2%
5,710,510
-5.4%
0.84%
+21.2%
Q3 2022$116,389,909
-18.4%
6,036,821
+7.8%
0.70%
-10.9%
Q2 2022$142,697,025
-1.0%
5,602,5530.0%0.78%
+28.8%
Q1 2022$144,097,663
-37.8%
5,602,553
+1.2%
0.61%
-27.5%
Q4 2021$231,846,000
-7.5%
5,537,291
-3.9%
0.84%
-4.6%
Q3 2021$250,721,000
-5.5%
5,761,045
+2.7%
0.88%
-1.2%
Q2 2021$265,329,000
-6.2%
5,611,875
+1.7%
0.89%
-19.9%
Q1 2021$282,941,000
+92.1%
5,518,644
+0.3%
1.11%
+75.2%
Q4 2020$147,290,000
-22.0%
5,499,9990.0%0.63%
-34.0%
Q3 2020$188,815,000
-16.2%
5,499,9990.0%0.96%
-28.7%
Q2 2020$225,335,000
+19.6%
5,499,9990.0%1.34%
-3.2%
Q1 2020$188,485,000
+172.5%
5,499,9990.0%1.39%
+207.3%
Q4 2019$69,162,0005,499,9990.45%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders